Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective, Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B

NCT06926647 is registered in ClinicalTrials.gov with Beijing 302 Hospital as lead sponsor.

NCT NCT06926647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06926647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective, Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B
Lead sponsor
Beijing 302 Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
May 1, 2025
Completion date
December 31, 2028
Enrollment
2,000 (estimated)
Sites
85

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b, hbv